LAS VEGAS — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed the use of megaprosthesis for non-oncologic limb salvage yielded significant complication risk and an elevated revision rate at 5 years.
“Overall, megaprosthetics clearly trail behind other forms of revision in arthroplasty and augments with high rates of subsequent revision and complications,” Victoria Oladipo, BS, said in her presentation here. “However, this might still be good for people of certain populations, and they can delay or possibly even avoid